A recent pharmacoepidemiological study indicates that older adults who receive the recombinant #shingles vaccine (Shingrix) exhibit a 24% lower risk of being diagnosed with #dementia over a four-year period compared to unvaccinated peers.
#Pharmacoepidemiology #Gerontology #Neurology #Immunology #PublicHealth #sflorg
https://www.sflorg.com/2026/06/phar06162601.html